United States - English - NLM (National Library of Medicine)

dexcel pharma technologies ltd. - chlorhexidine gluconate (unii: mor84mud8e) (chlorhexidine - unii:r4ko0dy52l) - chlorhexidine gluconate 2.5 mg - periochip is indicated as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis. periochip may be used as a part of a periodontal maintenance program, which includes good oral hygiene and scaling and root planing. periochip should not be used in any patient who has a known sensitivity to chlorhexidine.

United States - English - NLM (National Library of Medicine)

dexcel pharma technologies ltd. - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - omeprazole 20 mg

United States - English - NLM (National Library of Medicine)

dexcel pharma technologies ltd. - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 23 mg - donepezil hydrochloride tablets are indicated for the treatment of dementia of the alzheimer's type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer's disease. donepezil hydrochloride is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. pregnancy category c there are no adequate or well-controlled studies in pregnant women. donepezil hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of donepezil to pregnant rats and rabbits during the period of organogenesis did not produce any teratogenic effects at doses up to 16 mg/kg/day (approximately 6 times the maximum recommended human dose [mrhd] of 23 mg/day on a mg/m 2 basis) and 10 mg/kg/day (approximately 7 times the mrhd on a mg/m 2 basis), respectively. oral administration of donepezil (1, 3, 10 mg/kg/day) to rats during late gestation and th

Israel - English - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - tablets prolonged release - tramadol hydrochloride 100 mg - tramadol - tramadol - treatment of moderate to severe pain.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - tablets prolonged release - tramadol hydrochloride 200 mg - tramadol - tramadol - treatment of moderate to severe pain.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - tablets prolonged release - tramadol hydrochloride 300 mg - tramadol - tramadol - treatment of moderate to severe pain.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - tablets prolonged release - tramadol hydrochloride 100 mg - tramadol - tramadol - treatment of moderate to severe pain.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - tablets prolonged release - tramadol hydrochloride 200 mg - tramadol - tramadol - treatment of moderate to severe pain.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - tablets prolonged release - tramadol hydrochloride 300 mg - tramadol - tramadol - treatment of moderate to severe pain.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - risperidone - tablets - risperidone 1 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors